Unknown

Dataset Information

Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.


ABSTRACT:

Purpose

We recently reported the development of a cell-free DNA (cfDNA) targeted methylation (TM)-based sequencing approach for a multi-cancer early detection (MCED) test that includes cancer signal origin prediction. Here, we evaluated the prognostic significance of cancer detection by the MCED test using longitudinal follow-up data.

Experimental design

As part of a Circulating Cell-free Genome Atlas (CCGA) substudy, plasma cfDNA samples were sequenced using a TM approach, and machine learning classifiers predicted cancer status and cancer signal origin. Overall survival (OS) of cancer participants in the first 3 years of follow-up was evaluated in relation to cancer detection by the MCED test and clinical characteristics.

Results

Cancers not detected by the MCED tes

SUBMITTER: Chen X 

PROVIDER: S-EPMC9401481 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature